medtherapy biotechnology

Auto Added by WPeMatico

9.5% stake due diligence fema Finance hemal mehta med therapy medtherapy biotechnology overseas investment sachin mehta sebi lodr sudarshan pharma

Sudarshan Pharma Says Proposed 9.5% Stake Acquisition in US Firm Under Due Diligence

September 15, 2026
Finance

New Delhi [India], September 15: Sudarshan Pharma Industries Ltd has provided an update on its proposed acquisition of a 9.5% equity stake in US-based Med Therapy Biotechnology Inc., stating that the transaction is currently under due diligence. In a regulatory filing dated September 15, the company said the proposal to acquire the 9.5% stake in […]

Sairam Yuvak Mandal to celebrate 29th Ganesh Mahotsav with ‘Konark Sun Temple’ theme

Ryan Group of Schools Hosts the 24th Indian Model United Nations in the Capital

Can Fin Homes Showcases ‘Project Tejas’, its Rs 296.95-Crore Enterprise Digital Transformation Programme

Valiance Solutions Launches Audit AI, a New Point Solution Built on Its Multimodal Platform, to Automate End-to-End Audit Verification

The Design Village, L’École de Design Nantes Atlantique Launch TNDV Dual Degree Programme Between India and France

medtherapy biotechnology

Sudarshan Pharma Says Proposed 9.5% Stake Acquisition in US Firm Under Due Diligence